AU2860401A - Compositions comprising nucleic acids incorporated in bilaminar mineral particles - Google Patents

Compositions comprising nucleic acids incorporated in bilaminar mineral particles

Info

Publication number
AU2860401A
AU2860401A AU28604/01A AU2860401A AU2860401A AU 2860401 A AU2860401 A AU 2860401A AU 28604/01 A AU28604/01 A AU 28604/01A AU 2860401 A AU2860401 A AU 2860401A AU 2860401 A AU2860401 A AU 2860401A
Authority
AU
Australia
Prior art keywords
bilaminar
compositions
nucleic acids
mineral particles
acids incorporated
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU28604/01A
Inventor
Bruno Pitard
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharma SA
Original Assignee
Aventis Pharma SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR9916707A external-priority patent/FR2803206A1/en
Application filed by Aventis Pharma SA filed Critical Aventis Pharma SA
Publication of AU2860401A publication Critical patent/AU2860401A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1611—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Inorganic Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
AU28604/01A 1999-12-30 2000-12-27 Compositions comprising nucleic acids incorporated in bilaminar mineral particles Abandoned AU2860401A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
FR9916707 1999-12-30
FR9916707A FR2803206A1 (en) 1999-12-30 1999-12-30 New composition, used in in vitro or ex vivo cellular transfection, comprises a nucleic acid and a mineral particle with an exchangeable layer structure
US18567900P 2000-02-28 2000-02-28
US60185679 2000-02-28
PCT/FR2000/003702 WO2001049869A1 (en) 1999-12-30 2000-12-27 Compositions comprising nucleic acids incorporated in bilaminar mineral particles

Publications (1)

Publication Number Publication Date
AU2860401A true AU2860401A (en) 2001-07-16

Family

ID=26235199

Family Applications (1)

Application Number Title Priority Date Filing Date
AU28604/01A Abandoned AU2860401A (en) 1999-12-30 2000-12-27 Compositions comprising nucleic acids incorporated in bilaminar mineral particles

Country Status (7)

Country Link
EP (1) EP1246931A1 (en)
JP (1) JP2003519241A (en)
AU (1) AU2860401A (en)
CA (1) CA2395742A1 (en)
IL (1) IL150476A0 (en)
MX (1) MXPA02006528A (en)
WO (1) WO2001049869A1 (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2826279A1 (en) * 2001-06-26 2002-12-27 Aventis Pasteur VACCINE COMPOSITION COMPRISING A HYDROTALCITE TYPE COMPOUND
DE10237518A1 (en) * 2002-08-16 2004-02-26 Süd-Chemie AG Removing biomolecules from liquid media, useful for purification, product recovery or preparation of vectors, comprises retention on hydrotalcite of controlled particle size
WO2006138145A1 (en) 2005-06-14 2006-12-28 Northwestern University Nucleic acid functionalized nanoparticles for therapeutic applications
DE102005060392A1 (en) 2005-12-16 2007-06-21 Süd-Chemie AG Separating proteins from liquid media, useful e.g. for isolation of proteins from bioreactors or body fluids, using specific clay material that does not swell much in water
CA2691066C (en) 2007-02-09 2018-07-31 Northwestern University Particles for detecting intracellular targets
US8808747B2 (en) * 2007-04-17 2014-08-19 Baxter International Inc. Nucleic acid microparticles for pulmonary delivery
CA2689923A1 (en) 2007-05-30 2008-12-11 Northwestern University Nucleic acid functionalized nanoparticles for therapeutic applications
MX2011005429A (en) 2008-11-24 2011-06-21 Univ Northwestern Polyvalent rna-nanoparticle compositions.
US20100233270A1 (en) 2009-01-08 2010-09-16 Northwestern University Delivery of Oligonucleotide-Functionalized Nanoparticles
CA2779099C (en) 2009-10-30 2021-08-10 Northwestern University Templated nanoconjugates
WO2013040499A1 (en) 2011-09-14 2013-03-21 Northwestern University Nanoconjugates able to cross the blood-brain barrier
US10894963B2 (en) 2013-07-25 2021-01-19 Exicure, Inc. Spherical nucleic acid-based constructs as immunostimulatory agents for prophylactic and therapeutic use
CN106535876B (en) 2014-06-04 2020-09-11 埃克西奎雷股份有限公司 Multivalent delivery of immunomodulators through liposomal spherical nucleic acids for prophylactic or therapeutic applications
EP3220895B1 (en) 2014-11-21 2022-08-31 Northwestern University The sequence-specific cellular uptake of spherical nucleic acid nanoparticle conjugates
WO2018039629A2 (en) 2016-08-25 2018-03-01 Northwestern University Micellar spherical nucleic acids from thermoresponsive, traceless templates
WO2018209270A1 (en) 2017-05-11 2018-11-15 Northwestern University Adoptive cell therapy using spherical nucleic acids (snas)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3414539B2 (en) * 1994-05-11 2003-06-09 有限会社ドット Composition for nasal absorption
JP2000503000A (en) * 1995-12-21 2000-03-14 クエスト・インターナショナル・ビー・ブイ Granular composition
KR100359716B1 (en) * 1998-09-11 2003-04-21 (주)나노하이브리드 Live-inorganic hybrid complexes capable of storing and transferring genes and methods of manufacturing the same

Also Published As

Publication number Publication date
IL150476A0 (en) 2002-12-01
CA2395742A1 (en) 2001-07-12
JP2003519241A (en) 2003-06-17
MXPA02006528A (en) 2002-11-29
EP1246931A1 (en) 2002-10-09
WO2001049869A1 (en) 2001-07-12

Similar Documents

Publication Publication Date Title
IL148843A0 (en) Immunostimulatory nucleic acids
AU2860401A (en) Compositions comprising nucleic acids incorporated in bilaminar mineral particles
AU2001249251A1 (en) Novel nucleic acids and polypeptides
AU2001243142A1 (en) Novel nucleic acids and polypeptides
AU2001234944A1 (en) Novel nucleic acids and polypeptides
AU2001290548A1 (en) Novel nucleic acids and polypeptides
AU2001245280A1 (en) Novel nucleic acids and polypeptides
AU2001233041A1 (en) Novel nucleic acids and polypeptides
AU2001238347A1 (en) Novel nucleic acids and polypeptides
AU2001296235A1 (en) Novel nucleic acids and polypeptides
AU2001267191A1 (en) Capture moieties for nucleic acids and uses thereof
AU2001233017A1 (en) Novel nucleic acids and polypeptides
AU6516000A (en) Nucleic acids encoding zinc metalloproteases
AU2001241511A1 (en) Novel nucleic acids and polypeptides
AU2001250872A1 (en) Novel nucleic acids and polypeptides
AU2001277840A1 (en) Novel nucleic acids and polypeptides
AU2001276023A1 (en) Materials and methods for binding nucleic acids to surfaces
EP1080225A4 (en) Compositions and methods for the pulmonary delivery of nucleic acids
AU2970299A (en) Compositions and methods for polynucleotide delivery
AU2710400A (en) Monocyte-derived nucleic acids and related compositions and methods
AU3511100A (en) Novel nucleic acids and polypeptides
AU2600100A (en) Methods and compositions for delivering nucleic acids
AU7563798A (en) Methods and compositions for administering dna to mucosal surfaces
AU4007899A (en) Compositions and methods for the pulmonary delivery of nucleic acids
AU5377599A (en) Nucleic acids

Legal Events

Date Code Title Description
MK1 Application lapsed section 142(2)(a) - no request for examination in relevant period